BIOGEN INC. (BIIB) Deferred Tax Assets, Valuation Allowance USD 2010 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Biogen Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2010 to 2023.
  • Biogen Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $1.28B, a 36.2% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.28B -$725M -36.2% Dec 31, 2023 10-K 2024-02-14
Q3 2023 $85M $0 0% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $85M $0 0% Jun 30, 2023 10-Q 2023-07-25
Q1 2023 $85M $0 0% Mar 31, 2023 10-K 2024-02-14
Q4 2022 $2B +$42M +2.14% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $85M Sep 30, 2022 10-Q 2022-10-25
Q2 2022 $85M -$290M -77.3% Jun 30, 2022 10-Q 2022-07-20
Q1 2022 $85M Mar 31, 2022 10-K 2023-02-15
Q4 2021 $1.96B +$207M +11.8% Dec 31, 2021 10-K 2023-02-15
Q2 2021 $375M Jun 30, 2021 10-Q 2021-10-20
Q4 2020 $1.75B +$1.75B +159345% Dec 31, 2020 10-K 2022-02-03
Q4 2019 $1.1M -$18.9M -94.5% Dec 31, 2019 10-K 2021-02-03
Q4 2018 $20M +$3.4M +20.5% Dec 31, 2018 10-K 2020-02-06
Q4 2017 $16.6M +$500K +3.11% Dec 31, 2017 10-K 2019-02-06
Q4 2016 $16.1M +$2M +14.2% Dec 31, 2016 10-K 2018-02-01
Q4 2015 $14.1M +$2.6M +22.6% Dec 31, 2015 10-K 2017-02-02
Q4 2014 $11.5M +$10M +667% Dec 31, 2014 10-K 2016-02-03
Q4 2013 $1.5M -$10.8M -87.8% Dec 31, 2013 10-K 2015-02-04
Q4 2012 $12.3M +$1.5M +13.9% Dec 31, 2012 10-K 2014-02-06
Q4 2011 $10.8M $0 0% Dec 31, 2011 10-K 2013-02-05
Q4 2010 $10.8M Dec 31, 2010 10-K 2012-02-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.